Experienced in Neurofibromatosis Type 2 (NF2)

Dr. Michael J. Glantz

Neurosurgery | Neurology
Berkshire Faculty Services Inc
777 N Street 5th Floor, Neurological Services Of B, 
Pittsfield, MA 
Experienced in Neurofibromatosis Type 2 (NF2)
Berkshire Faculty Services Inc
777 N Street 5th Floor, Neurological Services Of B, 
Pittsfield, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Glantz is a Neurosurgery specialist and a Neurologist in Pittsfield, Massachusetts. Dr. Glantz is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Brain Tumor, and Thrombectomy.

His clinical research consists of co-authoring 69 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neurofibromatosis Type 2 (NF2).

Specialties
Neurosurgery
Neurology
Licenses
Neurological Surgery in PA
Hospital Affiliations
North Adams Regional Hospital Corporation
Berkshire Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

BERKSHIRE FACULTY SERVICES INC
777 N Street 5th Floor, Neurological Services Of B, Pittsfield, MA 01201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients With Primary Central Nervous System Lymphoma (PCNSL)
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
A Phase I/II Study of the Combination of Indoximod and Temozolomide for Adult Patients With Temozolomide-Refractory Primary Malignant Brain Tumors
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
A Biospecimen Collection Study to Evaluate the Pharmacokinetic, Pharmacodynamic, and Resistance Profile to Trametinib and Dabrafenib in BRAF-V600E Mutated Recurrent Gliomas
Enrollment Status: Terminated
Publish Date: October 06, 2023
Intervention Type: Procedure
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

71 Total Publications

Prophylactic Intraventricular Vancomycin: A Potential Paradigm Shift in Ommaya Reservoir-Associated Infection Prevention.
Prophylactic Intraventricular Vancomycin: A Potential Paradigm Shift in Ommaya Reservoir-Associated Infection Prevention.
Journal: World neurosurgery
Published: October 17, 2025
Similar Doctors
Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Alexis Demopoulos
Neurology
Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Alexis Demopoulos
Neurology

Hartford Hospital

80 Seymour St, 
Hartford, CT 
 (56.8 miles away)
860-545-7500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alexis Demopoulos is a Neurologist in Hartford, Connecticut. Dr. Demopoulos is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Brain Tumor, Glioblastoma, Glioma, and Astrocytoma.

Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Thomas J. Lovely
Neurosurgery | General Surgery
Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Thomas J. Lovely
Neurosurgery | General Surgery
1182 Troy Schenectady Rd Suite 100, St. Peter's Hospital Spine And Neurosurgery, 
Latham, NY 
 (35.7 miles away)
518-713-5400
Languages Spoken:
English
See accepted insurances

Thomas Lovely is a Neurosurgery specialist and a General Surgeon in Latham, New York. Dr. Lovely is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Subdural Hematoma, Spinal Stenosis, Posterior Fossa Tumor, Microdiscectomy, and Herniated Disc Surgery.

Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Kelly Donnelly
Neurology
Experienced in Neurofibromatosis Type 2 (NF2)
Dr. Kelly Donnelly
Neurology

Albany Medical College

47 New Scotland Ave, 
Albany, NY 
 (29.2 miles away)
518-262-5633
Languages Spoken:
English
See accepted insurances

Kelly Donnelly is a Neurologist in Albany, New York. Dr. Donnelly is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). Her top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Generalized Tonic-Clonic Seizure, and Seizures.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Glantz's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile